News | Cardiovascular Ultrasound | June 13, 2016

Study Finds Strain Echo Good Evaluator for Hypertrophic Cardiomyopathy Risk Assessment

Results convey hope for common condition that often goes undetected and results in sudden cardiac death

hypertrophic cardiomyopathy, HCM, strain echocardiography, risk assessment, ASE 2016

June 13, 2016 – After following a large sub-set of patients, researchers found that by using strain echocardiography they could accurately predict which patients were likely to have complications from hypertrophic cardiomyopathy (HCM). This is important because HCM is common, but often undetected, and one of the leading causes of sudden cardiac death in young adults.

“HCM is the most common inherited cardiac condition with several disabling and life-threatening complications. Global longitudinal strain was able to independently predict key outcomes in HCM and therefore has the potential to become an essential tool in HCM risk assessment,” said Hongyun Liu, M.D., of the Johns Hopkins HCM Center of Excellence, Baltimore.

Conventional and strain echocardiography were performed in 400 HCM patients who were followed for 37 months to obtain the necessary data. Strain echocardiography is an advanced but growing cardiovascular diagnostic technique that is a sensitive and powerful way to assess patient outcomes.

Researchers on the study, “Global Longitudinal Strain Independently Predicts Outcomes in Hypertrophic Cardiomyopathy,” included Liu, Iraklis Pozios, Bereketeab Haileselassie, Alexandra Nowbar, Lars Sorensen, Susan Phillip, Dai-Yin Lu, Ioannis Ventoulis, Hongchang Luo, Roselle Abraham and Theodore Abraham from Johns Hopkins HCM Center of Excellence.

HCM can affect people of any age and affects men and women equally. It is a disease in which the heart muscle (myocardium) becomes abnormally thick (hypertrophied). The thickened heart muscle can make it harder for the heart to pump blood. Some people who have HCM have no signs or symptoms, and the disease does not affect their lives. Others may have shortness of breath, serious arrhythmias or an inability to exercise. Although HCM is usually inherited, it can also develop over time because of high blood pressure or aging. 

Liu presented a poster based on this research during the American Society of Echocardiography (ASE) 27th Annual Scientific Sessions, June 10-14 in Seattle.

For more information: www.asescientificsessions.org

Related Content

Biotronik Studies Demonstrate Efficacy of Minimizing Metal Burden in SFA Therapy
News | Stents Bare Metal| September 22, 2017
Physicians demonstrated that reducing metal burden in superficial femoral artery (SFA) therapy could effectively reduce...
Edwards Inspiris Resilia Valve Receives FDA Approval
News | Heart Valve Technology| September 21, 2017
Edwards Lifesciences Corp. recently received U.S. Food and Drug Administration (FDA) approval for its Inspiris Resilia...
MyoKardia Presents Additional Positive Data From Phase 2 PIONEER-HCM Study at HFSA 2017
News | Heart Failure| September 21, 2017
MyoKardia Inc. announced that additional positive data from the first patient cohort of its Phase 2 PIONEER-HCM study...
DISRUPT BTK Study Shows Positive Results With Lithoplasty in Calcified Lesions Below the Knee
News | Peripheral Artery Disease (PAD)| September 20, 2017
Shockwave Medical reported positive results from the DISRUPT BTK Study, which were presented at the annual...
Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Marijuana Associated With Three-Fold Risk of Death From Hypertension
News | Hypertension| September 14, 2017
Marijuana use is associated with a three-fold risk of death from hypertension, according to research published recently...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Medtronic Announces Japanese Regulatory Approval for In.Pact Admiral Drug-Coated Balloon
News | Drug-Eluting Balloons| September 13, 2017
Medtronic plc announced that the In.Pact Admiral Drug-Coated Balloon (DCB) received approval from the Japanese Ministry...
Overlay Init